Submissions

All manuscripts must be submitted via the online portal at www.actapulmonologica.or.id

• Originality: Manuscripts must be original, have not been published previously, and are not currently under consideration by another journal. A similarity check (e.g., Turnitin) will be performed upon submission.
• Language: All manuscripts must be written in clear, concise US English. Authors whose first language is not English are encouraged to have their manuscripts proofread by a professional editor.

• Compliance: Manuscripts must adhere to the ICMJE "Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals."
• Editorial Authority: The Board reserves the right to edit for style, clarity, and format. Manuscripts with significant linguistic or formatting errors may be rejected or returned for revision.
• Peer Review: All submissions undergo rigorous peer and editorial review.

Accepted Article Types

• Original Articles (Basic, Clinical, or Community Research) (ORI)
• Case Reports (CAS)
• Review Articles (REV)

Required Documents for Submission

• Completed ICMJE Conflict of Interest forms for all authors.
• Formal Cover Letter (including statements on prior presentations or redundant publication).
• Copy of Ethical Approval (if applicable).
• A Final Checklist signed by all authors.

Study Ethics & Informed Consent

• Institutional Review: Any study involving human subjects or animal experimentation must include a statement of approval from an independent ethics committee.
• Patient Privacy: In accordance with global data protection standards, all identifiers (names, birth dates, medical record numbers) must be removed.
• Visual Data: Patient faces must be blurred; eyes should be concealed with black bars. De-identification is required for all diagnostic imaging (CT, X-ray, Ultrasound).
• Consent: Written informed consent for publication is mandatory. If a waiver was granted by an ethics committee, the official waiver letter must be uploaded.
• Clinical Trials: Must be registered in a public database (e.g., gov or WHO ICTRP) prior to the start of the study. The registration number must be listed at the end of the abstract.
• Systematic Reviews: Registration with PROSPERO is strongly encouraged before data extraction begins.

Formatting

• File format: Microsoft Word (.doc or .docx)
• Font: Times New Roman, 12pt.
• Spacing: Double-spaced throughout.
• Margins: A4 paper size with 2.5 cm (1 inch) on all sides.
• Page numbers: Placed at the bottom right of each page.
• File Naming:  (First Author’s Surname)-(ORI/CR/REV).docx

Manuscript Structure

• Order: Title Page (submitted as a separate file for double-blind review), 2. Abstract and Keywords, 3. Main Text, 4. Conflicts of Interest & Funding Disclosures 5. Acknowledgments, 6. References,7. Tables, Figures, and Legends
• Title Page
  • Title: Concise and informative (max 20 words); capitalize each word.
  • Running Title: Max 140 characters including spaces.
  • Author Details: Includes the full title, author names, affiliations, and the corresponding author’s email.
• Abstract

• ORI: Structured (Background, Method, Result, Conclusion) – max 250 words.
• CAS/REV: Unstructured – max 150 words.
• Keywords: 3 to 10 terms, separated by commas.
• Main Text
• Original Article: Introduction, Methods, Results, and Discussion(IMRAD)
• Case Report: Intro, Background, Case Description, Discussion, Conclusion
• Review: Intro, Literature Review, Conclusion

Tables and Figures

• Tables and Figures must be numbered consecutively (e.g., Table 1, Figure 1) and cited in the text.
• Tables should be editable (not images) with a descriptive title above.
• Figures must be high resolution (minimum 300 dpi) in JPEG or TIFF format with captions below.
• It is recommended to limit the combined total of tables and figures to six.
• If using previously published material, authors must provide written permission from the copyright holder.

• Large datasets, videos, or extensive appendices may be submitted as supplementary materials.

Disclosure and Funding

• Conflict of Interest: Authors must declare any financial or personal relationships that could inappropriately influence their work. If none exist, state: "The authors declare no conflict of interest."
• Funding: Specify any sources of financial support for the research.
• Acknowledgement: Recognize individuals who contributed to the work but do not meet the criteria for authorship.

References

• Style: Follow the Vancouver
• Citations: Use Arabic numerals in superscript following the order of appearance.
• Management: Use of software like Mendeley, Zotero, or EndNote is highly recommended.

Journal Articles

1. Standard Article (Up to 6 authors):

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49.

2. More than 6 authors:

Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91(1):157-60.

3. Organization as Author:

Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2024 report. Madison (WI): GOLD; 2023.

4. Journal Article with DOI (Preferred for online-first):

Bousquet J, Anto JM, Bachert C, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 report. J Allergy Clin Immunol. 2020;145(1):70-80. doi: 10.1016/j.jaci.2019.06.049.

Books and Monographs

1. Personal Author(s):

Grippi MA, Antin-Ozerkis DE, Elias JA, Kotloff RM. Fishman's Pulmonary Diseases and Disorders. 6th ed. New York: McGraw Hill; 2023.

2. Chapter in an Edited Book:

Lumb AB, Thomas CR. Carbon dioxide. In: Lumb AB, Thomas CR, editors. Nunn's Applied Respiratory Physiology. 9th ed. St Louis (MO): Elsevier; 2020. p. 135-50.

Scientific Reports and Grey Literature

1. Government/Official Report:

World Health Organization. Global Tuberculosis Report 2023. Geneva: World Health Organization; 2023. Licence: CC BY-NC-SA 3.0 IGO.

2. Dissertation/Thesis:

Smith J. Precision medicine in interstitial lung disease [dissertation]. London: Imperial College London; 2022.

Electronic and Digital Media

1. Webpage/Homepage:

Centers for Disease Control and Prevention. Chronic Obstructive Pulmonary Disease (COPD) [Internet]. Atlanta: CDC; 2024 [updated 2024 Jan 15; cited 2024 Feb 10]. Available from: https://www.cdc.gov/copd/index.html

2. Preprint (Work not yet peer-reviewed):

Doe J, Roe R. Longitudinal lung function in post-viral syndrome. medRxiv. [Preprint]. 2023 [cited 2024 Jan 5]: [12 p.]. Available from: https://doi.org/10.1101/2023.01.01.23284000